Skip to content

Veradermics MANE Balance Sheet Statement

Q1 '26Q4 '25Q1 '25Q4 '24Q3 '24
$168.41M+674%$21.77M-32.9%$32.44M-38.9%$53.08M
$222.39M+85.2%$120.1M$0
$397.07M+160%$152.49M$55.54M
$21K-4.5%$22K$0
$287K+130%$125K$0
$397.36M+160%$152.62M$55.54M
$1.07M-49.6%$2.13M+410%-$686K-131%$2.25M+1,292%$161.5K0.0%
$6.72M-26.6%$9.15M$4.72M
$6.72M-26.6%$9.16M$4.72M
$1K$1K
-$150.65M-22.1%-$123.42M-$49.23M
$390.64M+423%-$121.01M-99.5%-$60.67M-25.1%-$48.48M
$397.36M+160%$152.62M$55.54M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Veradermics 's total assets?
Veradermics (MANE) holds $397.4M in total assets.
How much cash does Veradermics have?
Veradermics holds $168.4M in cash and equivalents.
Can Veradermics cover its short-term obligations?
Its current ratio is 59.12 — current assets exceed current liabilities.
Where does Veradermics 's balance sheet data come from?
Every line is extracted from Veradermics 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.